ATHENS, GEORGIA - May 12, 2022 : Infant baby formula product shortage. Empty Similac baby food shelves at an American grocery store supermarket (courtesy: Shutterstock)
Rev 6:6 NAS “And I heard something like a voice in the center of the four living creatures saying, “A quart of wheat for a denarius, and three quarts of barley for a denarius; and do not damage the oil and the wine.”
Important Takeaways:
- ISRAELI FIRM COMMITS TO SHIPPING 200,000 CANS OF BABY FORMULA TO US TO HELP SOLVE CRISIS
- An Israeli-based company hopes to fill the void
- Three weeks ago, the U.S. Food and Drug Administration issued emergency guidance enabling the import of infant formulas produced abroad.
- Tel Aviv-based MyOr—an Israeli health-tech company—is among companies seeking FDA approval as its Mexican subsidiary, AlphaCare, produces and markets MyOr formulas from a plant in north-central Mexico.
- “We have 200,000 cans of formula ready to be shipped right now, with a capacity to produce another 250,000 a month,” said MyOr co-founder and chief technology officer Michael Brandwein.
- Founded in 2018, MyOr provides preventive health-care solutions for infants at-risk with a specific focus on food allergies and nutritional sufficiency.
Read the original article by clicking here.
